Reconsideration of animal models of schizophrenia and other psychiatric disorders with evolutionary perspective. by Lee, Young-A & Goto, Yukiori
TitleReconsideration of animal models of schizophrenia and otherpsychiatric disorders with evolutionary perspective.
Author(s)Lee, Young-A; Goto, Yukiori
CitationMedical hypotheses (2013), 81(6): 1120-1126
Issue Date2013-12
URL http://hdl.handle.net/2433/179780







Reconsideration of Animal Models of Schizophrenia 





Young-A Lee, Ph.D. & Yukiori Goto, Ph.D.* 
 






Yukiori Goto, Ph.D. 
Kyoto University Primate Research Institute 









Number of Pages: 29 pages 
Title: 13 words 
Abstract: 97 words 



















Studies utilizing animal models for understanding biological mechanisms of such 
psychiatric disorders as schizophrenia have been now flourishing.  Animal models are 
a essential part of translational research, and without them, it is not possible to develop 
therapeutic strategies to treat psychiatric disorders.  Accordingly, importance of animal 
models have been increasingly emphasized.  However, on the other side, limitations of 
such an animal model approach has been growingly deceptive.  The aim of this review 
article is to discuss limitations of translational research utilizing animal models, and 
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Schizophrenia is a psychiatric disorder that has been under extensive investigation for 
long time.  Schizophrenia had been once said "the graveyard of neuropathologists" (1) 
because of unclear pathological changes in the brains of schizophrenia patients.  
However, tremendous efforts, especially with recent progresses of live human imaging 
techniques as well as genetic understanding and engineering technologies have made 
significant advancement for unveiling the mystery of schizophrenia.  Consequently, an 
optimistic belief has emerged that biological understanding of this psychiatric disorder 
is now within the hand, and we will eventually be able to cure the disorder.  
Nevertheless, the fact is that, for treatments of schizophrenia and most of other 
psychiatric disorders, we still do not have therapeutic methods based on the fruits of 
recent research, and have to rely on drugs that are based on the old serendipitous 
findings with considerable devastating side effects and that works in some, but not all 
patients.   
 Translational research, which is the process that develops new and better 
therapeutic drugs and strategies for human psychiatric disorders by applying findings in 
basic scientific research utilizing animals, has been currently a main research strategy 
(Fig. 1) (2, 3).  Animal models consist of an essential part of the translational research.  
Accordingly, importance of animal models have been increasingly emphasized.  In 
contrast, limitations of utilizing animal models to understand the biological mechanisms 
of psychiatric disorders has tended to be disregarded.  This review articles discusses 
limitations of translational research utilizing animal models for understanding such 
psychiatric disorders as schizophrenia, and provides a novel, alternative approach to 
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Animal models of schizophrenia 
 
Following three criteria have been proposed that animal models of psychiatric disorders 
have to fulfill; [i] construct validity, which is whether manipulations given in animals to 
create models have relations to the suggested causes of the disorders; [ii] face validity, 
which is whether alterations observed in animal models resemble to the symptoms of 
the disorders; and (4) predictive (pharmacological) validity, which is whether alterations 
in animal models are ameliorated by currently used pharmacotherapeutic drugs or other 
treatment methods in human patients (5).   
 Animal models of schizophrenia particularly require the following additional 
criteria (6); augmented responses to such psychostimulants as amphetamine and 
phencyclidine (PCP) and stress, which have been shown to precipitate or exacerbate 
symptoms in schizophrenia patients; decreased social interaction with mates, which 
resembles to the negative symptoms of schizophrenia; deficits in such sensory gating 
mechanisms as prepulse inhibition; and cognitive dysfunction, especially those relating 
to prefrontal cortical (PFC) function such as working memory, attention, and behavioral 
flexibility.  However, the criterion that appears to be most critical and relevant to 
schizophrenia is delayed onset of abnormalities.  Thus, models involve manipulations 
given in early development (i.e. prenatal and neonatal periods), but abnormalities are 
quiescent in childhood, but become apparent when animals reach young adulthood.  
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This development-dependent emergence of abnormalities resembles the typical onset 
age of the schizophrenia symptoms in late adolescence to young adulthood, especially 
in male patients (female patients also have the peak of onset age in early adulthood, but 
they have another second peak on later ages around 40 to 70 years old (7).  Such 
male-female difference of the onset age of the symptoms have been barely considered in 
animal model studies). 
 To date, many animal models of schizophrenia have been proposed, which can 
be roughly divided into (1) lesion models; (2) pharmacological models; and (3) genetic 
manipulation models.  Lesion models include neonatal hippocampus (8) and PFC 
lesion (9) in rodents as well as neonatal temporal lobe lesion in non-human primates 
(10).  These lesion models emphasize the face validity, which exhibit an assortment of 
behavioral alterations that are similar to the symptoms and abnormalities observed in 
schizophrenia patients.  However, these models are clearly short of the construct 
validity, as no clear brain damage has been confirmed in schizophrenia brains.  
Pharmacological models include prenatal exposure to methylazoxymethanol acetate 
(11), prenatal immune activation (12), and exposure to such psychostimulants as 
amphetamine (13) and PCP (14).  In pharmacological models, both construct and face 
validities are balanced.  Currently the main stream of animal model research is 
utilization of genetic models.  As more schizophrenia candidate genes are recently 
identified, an expanding number of genetic manipulation models have been now 
proposed (15, 16).  Genetic models emphasize the construct validity, but the models do 
not necessarily have to have a good face validity, as the aim of these genetic models is 
on endophenotype analyses, correlating dysfunction of a specific gene and a specific 





Limitations of animal model approach 
 
Translational research bases on the idea that fundamental molecular, biochemical, 
anatomical, and physiological architectures of animals (including rodents and 
non-human primates) and human brains are similar, such that findings in animals can be 
readily applicable to humans.  This may be partly true, but it is more likely a naive 
presumption.  However, limitations of translational research with utilization of animal 
models have been barely discussed to date. 
 One example that coins limitations of translational research with animal model 
approach is the case of the metabotropic glutamate receptor (mGluR) II/III agonist 
developed by the pharmaceutical company Eli Lilly.  The study by Moghaddam and 
Adams published in Science in 1998 (17) is the first that suggests potential therapeutic 
effects of an mGluRII/III agonist on schizophrenia symptoms.  They reported that the 
mGluRII/III agonist could reverse PCP-induced alterations in rodents.  In synergy with 
the glutamatergic hypothesis of schizophrenia (18) and subsequent many animal model 
studies supporting this first finding (19, 20), it appeared that the mGluRII/III agonist 
was the most promising novel therapeutic drug against schizophrenia.  Eli Lilly then 
developed the mGluRII/III agonist LY2140023, and conducted clinical trials.  The first 
phase II trial revealed significant therapeutic effects (21), but twice of subsequent phase 
II trials resulted in observation of no therapeutic effects of this drug.  The reason why 
the drug had therapeutic effects in the first phase II trial, but not in subsequent trials, is 
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unknown.  However, the most important point is that in animal model studies, almost 
all cases have clearly demonstrated significant therapeutic potential of the mGluRII/III 
agonist. 
 Although this failure may be associated with difference of drug metabolisms 
that determine pharmacological responses between humans and animals, it is possible 
that it may also reflect limitations of animal model approach.   
 First, the limitation is associated with a question whether human brain is a 
scaled-up version of that in such animals as non-human primates and rodents.  For 
instance, Elston and colleagues have shown that dendritic spine density of cortical 
neurons in humans are about twice of that in rhesus macaques and triple of that in 
marmosets (22).  This finding can be interpreted in two ways.  One is that human 
brain is scaled-up version of monkey brain.  The current translational research is based 
on this interpretation.  Indeed, brains of humans and animals including non-human 
primates undoubtedly share some common mechanisms.  The other is that this 
difference of the spine density is a crucial factor that distinguishes humans and 
non-human primates and something that we should not ignore.  If emergence of such 
psychiatric disorders as schizophrenia originates in the common mechanisms between 
humans and animals, the current translational research will eventually come up into 
understanding of the disorders and development of new therapeutic strategies.  On the 
other hand, if emergence of the disorders may nest in such difference between humans 
and animals, the current approach of translational research may not be able to reach the 
answer. 
 The second limitation is that the criteria for animal models are mostly based on 
indecisive evidence of human cases.  In schizophrenia, a number of promising 
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molecular, anatomical, and physiological changes have been reported (23).  However, 
most of them have not been well replicated.  Nevertheless, these alterations, although 
supported by only weak evidence, have been accepted as the criteria in animal models.  
For instance, cognitive dysfunction has been suggested as the "core" deficit underlying 
schizophrenia (24).  Cognitive dysfunction can be also assessed in animals, such that 
cognitive dysfunction has been utilized as an important criterion in animal models of 
schizophrenia.  Nonetheless, it is particularly important to note that not all 
schizophrenia patients exhibit cognitive deficits.  In fact, it has been estimated that up 
to 75% of schizophrenia patients exhibit clear cognitive dysfunction, suggesting that 
cognitive function in at least one fourth of schizophrenia patients are still within a 
normal level (25).  One explanation for this observation is that some schizophrenic 
patients have even higher cognitive function than normal subjects before symptom onset, 
and cognitive decline results in normal range of function in these patients.  However, 
this argument does not explain why such schizophrenic patients with normal level of 
cognitive function still have to suffer from the symptoms and social malfunctioning.  A 
feasibility for the argument of cognitive dysfunction as the core deficit of schizophrenia 
is further weakened by the fact that cognitive dysfunction can be observed in most of 
other psychiatric disorders.  A deficit in sensory gating such as prepulse inhibition has 
been also considered as an important factor in schizophrenia.  However, deficits in 
prepulse inhibition are also observed in other psychiatric conditions (26-28).   
 The third limitation involves assessment methods for animal models.  For 
instance, decreased amount of social interaction with mates is one of the important 
criteria utilized in animal models of schizophrenia (6).  However, it is not possible to 
assess whether such decreased social interaction is due to increased fear, decreased 
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interest, or decreased motivation to interact with mates.  In schizophrenia, decreased 
social interaction may be associated with a mixture of fear and decreased motivation to 
interact with others, whereas in autism, it may be associated with a mixture of increased 
fear and decreased interest to interact with others.  Although outcome appears to be 
very similar, if not identical, the mechanisms underlying the outcome are often different, 
which cannot be distinguished in animal models. 
 It is interesting to note that a similar difficulty on developing new and better 
therapeutic drugs and treatment methods for stroke based on animal models has been 
also raised (29).  In animal model studies, almost 500 therapeutic drugs and methods 
have been suggested to be effective for treatments of stroke; nevertheless, only two 
drugs (aspirin and recombinant tissue plasminogen activator) have been confirmed to 




Psychiatric disorder-associated behavior in animal society 
 
In addition to the above discussion, another question is whether it is really appropriate 
to construct psychiatric disorder models using animals themselves.  
 Psychiatric and neurological disorders have been barely reported in wild 
animals including non-human primates.  There is no report of psychiatric disorders 
even in such hominidae primates as chimpanzees, orangutans, and gorillas that are 
species closest to humans.  There are two possible explanations for this fact.  One is 
that psychiatric conditions happen only with the human brain structure.  Alternately, 
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psychiatric conditions may present in animals, but such conditions exist as normal ones 
to them.  Psychiatric disorders are considered as maladaptation causing disadvantages 
within the human social system constructed by the majority of so-called "normal" 
people (Fig. 2).  When the social systems in which organisms are living are different, 
then meaning of psychiatric disorder-associated behavior becomes different.  For 
instance, if subjects with schizophrenia became a majority, and so-called normal people 
became a minority in the human social system, the structure of the social system could 
be reorganized such that schizophrenia symptoms were accepted as normal or 
advantageous behavior in the reorganized social system.  Therefore, psychiatric 
disorder-associated behavior may not necessarily be disadvantages, but whether such 
behavior is advantageous or disadvantageous can be determined only in relation with 
environments in which organisms are living.  One example illustrating this aspect is 
attention deficit/hyperactivity disorder (ADHD) (30).  ADHD consists of hyperactivity, 
impulsivity, and attention deficit with incapability to sustain attention to a particular 
target.  These symptoms are maladaptive and disadvantageous in the modern human 
social system such as school.  However, these symptoms are clearly advantageous in 
environment where a life-threatening danger is approaching.  Hyperactivity and 
inattention enables to detect quicker detection, and impulsivity enables to make quick 
decision to escape from the danger. 
 Therefore, it is possible that normal behavior and thereby brain function and 
structures of animals may be already similar to the conditions of psychiatric disorders in 
humans.  If this is true, a doubt arises on how useful to conduct artificial manipulations 
in animals whose brains are already similar to those of psychiatric conditions to create 





Difficulties of creating animal models of schizophrenia and autism  
 
A question whether animal models, especially those of schizophrenia and autism, are 
appropriate also comes from the oppositional relationships between these disorders.  
Thus, creating animal models of these disorders appears to be very difficult, based on 
the arguments that normal behavior and thereby normal brain function of animals may 
be already autistic, whereas schizophrenia may be associated with human-specific brain 
mechanisms. 
 Crespi and Badcock have suggested that schizophrenia and autism share many 
commonalities, but most of which are in the opposite directions, (31).  Crespi and 
colleagues have also provided evidence in their elegant study that schizophrenia and 
autism are also considered oppositional disorders in genetics  (32).  They have shown 
that schizophrenia and autism share many susceptible genes.  Moreover, prolongation 
and shortening of copy number variations in some of these genes are opposite between 
the disorders.  
 Oppositional alterations in some of brain function between schizophrenia and 
autism are particularly interesting.  The mechanisms of visual information integration 
appear to be altered in both schizophrenia and autism.  Gestalt perception such as 
Kanizsa's triangle (Fig. 3a) requires integration of visual information to see an 
illusionary figure (33).  An embedded figures test is to find a particular shape written 
over complex figures (Fig. 3b), which requires dissociation of the figures into each 
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component (34).  Therefore, Gestalt perception and an embedded figure test require 
opposite visual information processing.  Although results are still inconclusive, 
prodoromal phase or early stage of schizophrenia patients (35, 36) have been shown 
superior performance to normal subjects on gestalt perception, whereas subjects with 
autism (37, 38) are superior to normal subjects on an embedded figure test.  These 
studies suggest that the mechanism of visual information integration is abnormally 
augmented in schizophrenia, whereas it is underdevelopment in autism.  In relation to 
this issue, it has been suggested that the local neural network connections within the 
PFC is abnormally enhanced, whereas connections between the PFC and other brain 
structures are attenuated in autism (Fig. 4a) (39).  Frontotemporal dementia is a 
neurological disorder with selective degeneration between the PFC and temporal cortex, 
thus producing disconnection between these two cortical regions (40).  Patients with 
frontotemporal dementia exhibit stereotypy, restricted interest only to a specific object, 
impulsive and inflexible behavior, decreased spontaneous conversation, attenuated 
ability of visual information integration that is often expressed as an artistic ability (41), 
all of which are also the characteristics of autistic symptoms.  In schizophrenia, 
dysconnectivity, with connections between the PFC and some of other brain structures 
abnormally augmented, has been suggested (Fig. 4b) (42).  This is supported by 
functional imaging studies showing abnormal presence of connectivity between the PFC 
and temporal cortex, which is usually absent in normal subjects, in schizophrenia 
patients while engaging in cognitive tasks (43, 44). 
 Temple Grandin, who is autistic by herself, have suggested that behavior and 
the way of thinking in autism are similar to those of animals (45).  There is no direct 
evidence to support this argument, and therefore, it is mostly speculation.  However, it 
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is notable that several characteristic behavior of autism such as avoidance of eye contact, 
which is a sign of intimation in animals, limited language communication, fear as 
primary emotion, and difficulty in gestalt perception, are very similar to animal-like 
traits.  Victor of Aveyron (1788-1828) was a boy who was found living in the woods of 
Aveyron in the South-Central France.  His behavior was described by the doctor Jean 
Marc Gaspard Itard.  It is suggested that the behavior of Victor, if he had been living in 
the modern society, would have been diagnosed as autism (46).  It is possible that 
growing in the wild environment made Victor autistic-like.  Alternately, it is also 
possible that Victor was thrown by parents because of autism, but could survive in the 
wild environment owing to the autistic-traits (such as avoidance of eye contact).  In 
relation to this issue, alterations of the theory of mind in schizophrenia and autism are 
also interesting.  The theory of mind is an ability to estimate mental states of others.  
Whether the theory of mind is an unique function of humans or not is a matter of debate 
(47).  However, even if the theory of mind is present in animals, it is likely that this 
function is most developed in humans compared to any other species of animals.  
Autism has been shown to exhibit a deficit in the theory of mind (48).  A deficit in the 
theory of mind has been also reported in schizophrenia patients (49, 50).  Nonetheless, 
the deficit in schizophrenia may be different from that in autism.  With the positive 
symptoms such as delusion, schizophrenia patients often claim misrepresentation of 
mental states of others such as "neighbors are spying on them".  This may be explained 
by an abnormally exaggerated function of the theory of mind in schizophrenia.  A 
number of studies have shown association between a theory of mind deficit and 
delusion in schizophrenia patients (51, 52).  Therefore, the schizophrenic symptom, 
especially psychosis, may be emerged through evolution as a disadvantageous 
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Evolutionary approach for understanding psychiatric disorders 
 
Almost all biological psychiatric studies including translational research with animal 
models aim to unveil "how" psychiatric disorders are caused in humans ("proximate 
question" coined by Tinbergen (53)).  An alternate approach is to explore "why" 
psychiatric disorders exist in humans (Tinbergen`s "ultimate question").  To approach 
this ultimate question, investigation with evolutionary perspective is critical. 
 The epidemiological study by Power and colleagues has reported that fecundity 
of psychiatric patients is significantly lower than that in normal subjects (54).  In 
particular, fecundity of male subjects with schizophrenia and autism is only one fifth of 
normal subjects.  Fecundity of relatives of these patients is not significantly higher 
than that of normal subjects.  Collectively, although genetics play significant roles in 
both schizophrenia and autism, a chance of inheritance of susceptible genes that cause 
these disorders is very low.  This predicts decreasing percentage of afflicted subjects 
among population, and disorders eventually vanish over generation.  However, in 
reality, schizophrenia has been present among humans for as long as several thousand 
years, evidenced by descriptions of existence of schizophrenia-like subjects in such old 
scripts as Eber Papyrus (1500 BC, Egypt) and Atharva Veda (1400 BC, India) (55).  
The Darwinian natural selection theory predicts that disadvantageous phenotypes should 
have been vanished over generation.  Even the theory of Lamarckian inheritance of 
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acquired phenotypes predicts that disadvantageous phenotypes should not have been 
evolved.  Therefore, evolutionary perspective suggests that psychiatric disorders may 
not necessarily be disadvantageous, but could be advantageous phenotypes that have 
evolved as environmental adaptation or (still disadvantageous) by-products of such 
process.  Supporting evidence of this issue is still weak.  However, Crespi and 
colleagues have shown that traces of positive selection can be found on the 
schizophrenia and autistic candidate genes (56).  There is no direct evidence to support 
that schizophrenia is an advantageous change in evolution.  However, there have been 
a number of hypothesis arguing advantageous aspects of this disorder.  One of such 
hypotheses is the group-splitting hypothesis proposed by Stevens and Price (57).  They 
have proposed that schizophrenia may have a beneficial role to stabilize a group by 
splitting it into small ones when the group becomes too large and resources to support 
the group is scarce.  This hypothesis sounds attractive, since it is consistent with our 
idea discussed above that social stress yielded from over-crowdedness of the society 
may be driving force of evolution of the theory of mind, and psychosis may involve 
abnormal augmentation of the theory of mind. 
 Understanding biological mechanisms of psychiatric disorders as 
environmental adaptation with evolutionary perspective may be a fruitful direction of 








One way of investigation that can be an alternate over the current translational research 
for understanding psychiatric disorders is to examine how brain architectures and 
function are different between humans and animals (Fig. 5).  More specifically, 
investigation aims to examine difference of brain structure and function between 
humans and animals, and elucidate why such difference is created through evolution as 
environmental adaptation, and how such adaptation results in emergence of psychiatric 
conditions in humans.  In this approach, a hypothesis is that psychiatric disorders such 
as schizophrenia involves the brain mechanisms that are unique in humans.  Such an 
approach is the opposite direction of the current translational research.  Indeed, this 
approach is also different from the current research in which the current biological 
psychiatric research usually conduct experiments and make conclusions with only one 
specific species. 
 Another approach is use of domestic animals, especially canines, as an animal 
model.  In particular, social function of canines is atypical and distinct from that in 
wild animals.  Canines are highly sensitive to human social signals.  For instance, 
Canines have been shown to be able to learn behavior by observing behavior 
demonstrated by humans (58).  They can also use human eye signals for 
point-following.  Such an ability is not endowed in any other animals including 
chimpanzees, the non-human primates suggested to be closest to humans (59).  This 
hints a similar relationship between normal subjects and subjects with psychiatric 
disorders (Fig. 2).  Thus, atypical social behavior in canines can be considered as an 
"abnormal" social behavior from the view of wild animals.  Investigation for the 
biological mechanisms of how atypical social behavior has been evolved in canines may 
yield a novel insight for understanding the biological mechanisms of psychiatric 
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disorders with altered social function including schizophrenia.  In relation to this issue, 
it is notable that brains of canines seem to have evolved into an atypical condition and 
became closer to those of humans, as evidenced by spontaneously occurring 
Alzheimer's disease-like alterations in canine brains, but has never been reported in wild 
animals (60). 
 From the evolutionary perspective, the most important aspect of psychiatric 
disorders is that the disorders may have emerged as environmental adaptation or 
by-products of such adaptation processes.  In this regard, the Barker hypothesis is of 
particular interest (61).  The Barker hypothesis suggests that prenatal environment 
causes developmental adaptation in fetus to prepare for the expected environment in 
postnatal life.  For instance, insufficient nutrition during pregnancy lead to lower 
metabolism in fetus to maximize energy conservation for survival with a small amount 
of foods in the expected postnatal environment.  However, when such offspring with 
lower metabolism is exposed to normal nutrition after birth, the outcome is exceeding 
energy conservation over life, resulting in such diseases as cancer, diabetes, obesity, and 
cardiovascular diseases in adulthood.  Therefore, it is discrepancy between prenatal 
and postnatal environmental conditions, but not alterations associated with only prenatal 
or postnatal condition, that causes diseases.  Although the impacts of either prenatal or 
postnatal environment alone on neurodevelopment were extensively investigated, the 
impacts of prenatal and postnatal environmental interaction has been yet barely 
investigated.  However, for instance, there is one study by Leuba and Rabinowicz 
showing that offspring born from dams with diet restriction during pregnancy exhibits 
decreased dendritic spine density in cortical neurons when offspring was raised in 
normal postnatal nutrition.  However, such offspring was grown with restricted 
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nutrition, spine density was normalized (62).  Epidemiological studies have unveiled 
that antenatal maternal exposure to adverse environment such as famine, stress, and 
infection during pregnancy increases the risk of psychiatric disorders such as 
schizophrenia (63), autism (64), and ADHD (65) in offspring.  More recently, 
transgenerational inheritance of epigenetic changes (66-68) and altered behavior 
associated with specific environmental factors (69-72) have been reported.  Such 
transgenerational inheritance of epigenetic changes associated with prenatal 
environmental condition and altered neurodevelopment may therefore be biological 






We suggest that the current translation research approach utilizing animal models for 
understanding the biological mechanisms of such psychiatric disorders as schizophrenia 
has limitations.  Investigation with the evolutionary perspective may open a new venue 
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Figure 1. A schematic diagram illustrating the process of translational research.  
Studies with schizophrenia patients identify potential genetic and molecular changes 
associated with the disorder.  Based on these findings, manipulations are given in 
animals to examine how alterations cause alterations in animals to further understand 
underlying biological mechanisms.  A new pharmacological or other therapeutic 
method is then developed. 
 
Figure 2. A schematic diagram illustrating the relationship between normal subject and 
subjects with psychiatric disorders.   
 
Figure 3.  Examples of (a) gestalt perception (Kanizsa's triangle) and (b) embedded 
figures test.  In figure (a), an illusionary triangle can be seen in the middle.  In figure 
(b), the above figure is hidden in the bottom figure. 
 
Figure 4. Schematic diagrams of altered neural network connections between the PFC 
and other brain areas in (a) autism and (b) schizophrenia.  In autism, augmented 
over-connection (bold lines with arrows) of the local network within the PFC, whereas 
weakened connection (disconnectivity, dashed lines with arrows) between the PFC and 
other brain structures (denoted as A, B, C... in the figure) have been suggested.  In 
contrast, in schizophrenia, altered connection (dysconnectivity) between the PFC and 
other brain structures such as abnormal presence of functional connectivity, which is 






Figure 5.  A schematic diagram illustrating how the current translational research with 
an animal model approach and our proposed research with a comparative approach are 
different.  The current research strategy is to investigate the biological mechanisms 
underlying psychiatric disorders with presumption that fundamental aspects of brains of 
animals and humans are similar (the overlapping area in the figure).  In contrast, an 
alternate approach is to explore how brains of animals and humans are different to 
understand psychiatric disorders as unique conditions occurring in humans. 
 
 
 
 
 





